ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

セルトラリン塩酸塩

Sertraline Hydrochloride

HCID 63009
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
79559-97-0
標準SMILES
CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c2ccccc21.Cl
InChIKey
BLFQGGGGFNSJKA-XHXSRVRCSA-N
分子式
C17H18Cl3N
平均分子量
342.7 g/mol
単同位体質量
341.05048262

概要

Sertraline hydrochloride is a hydrochloride resulting from the reaction of equimolar amounts of sertraline and hydrogen chloride. A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as an antidepressant for the treatment of depression, obsessive-compulsive disorder, panic disorder and post-traumatic stress disorder. It has a role as an antidepressant and a serotonin uptake inhibitor. It contains a sertraline(1+).

名称と識別子

優先名称
Sertraline Hydrochloride
IUPAC
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride
現地名
セルトラリン塩酸塩
英語名
Sertraline hydrochloride
分子式
C17H18Cl3N
分子量
342.69

名称と別名

Sertraline hydrochloride79559-97-0Sertraline HCl(+)-sertraline hydrochlorideDTXSID1040243Sertraline (as hydrochloride)NSC-746308NSC-758948UTI8907Y6XCP-51974-1CHEBI:9124DTXCID9020243
名称をさらに表示
セルトラリン塩酸塩(1S,4S)-1-(3,4-ジクロロフェニル)-1,2,3,4-テトラヒドロ-4-(メチルアミノ)ナフタレン塩酸塩セルトラリン 塩酸塩塩酸セルトラリン塩酸セルトラリン (JAN)ジェイゾロフト(+)-(1S,4S)-4-(3,4-ジクロロフェニル)-N-メチル-1,2,3,4-テトラヒドロナフタレン-1-アミン=塩酸塩(1S,4S)-4-(3,4-ジクロロフェニル)-1,2,3,4-テトラヒドロ-N-メチル-1-ナフタレンアミン・塩酸塩(1S,4S)-4-(3,4-ジクロロフェニル)-N-メチル-1,2,3,4-テトラヒドロナフタレン-1-アミン・塩酸塩セルトラリン・塩酸塩SETRALINE HCLSERTRALINE MANDELATESertraline hydrochloSertraline hydrochloride impurity standardN-(4(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-1(2H)NAPHTHALIDENE) METHANAMINE(1S,4S)-4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-N-METHYL-1-NAPHTHALENAMINE HYDROCHLORIDE(1S,4S)-4-(3,4-Dichlorophenyl)-N-Methyl-1,2,3,4-tetrahydronaphthalen-1-aMine hydrochlorideCP-51974-1 HCl(1s-cis)-lorid
1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, hydrochloride, (1S-cis)-BesitronRefChem:6216Hydrochloride, SertralineSertraline Hydrochloride (1S-cis)-ZoloftGlademSerad

データベース識別子

CAS
79559-97-0、79617-89-3、79617-95-1
PubChem CID
63009
DTXSID
DTXSID1040243
ChEMBL
CHEMBL1709
ChEBI
CHEBI:9124
UNII
UTI8907Y6X
EC Number
616-702-0、616-708-3

物性

構造計算による物性

極性表面積
12 Ų
水素結合供与体数
2
水素結合受容体数
1
回転可能結合数
2
重原子数
21
形式電荷
0
複雑度
322

実験および物理化学的性質

Human Drugs · 2 件

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Collision Cross Section168.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
246 · 246-249°C
比旋光度
23 · D23 +37.9° (c = 2 in methanol)
比重(密度)
1.37 · 1.37
闪点
9 ℃ · 9℃
貯蔵温度
2 · 2-8°C
溶解性
26 mg/mL · DMSO: ~26 mg/mL
外見
個体
酸解離定数(Pka)
9.48 · pKa (water): 9.48 ± 0.04; pKa (methanol:water, 40:60 v/v): 8.6; pKa (ethanol:water, 1:1 v/v): 8.5(at 25℃)
色
白い
Merck
14 · 14,8467
安定性
冷凍庫で保存
InChI
InChI=1/C17H17Cl2N.ClH/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11;/h2-6,8,10,12,17,20H,7,9H2,1H3;1H/t12-,17-;/s3
InChIKey
BLFQGGGGFNSJKA-TYIRTQGFNA-N
SMILES
C12C=CC=CC=1[C@H](CC[C@H]2C1=CC=C(Cl)C(Cl)=C1)NC.Cl |&1:6,9,r|
CAS データベース
79559 · 79559-97-0(CAS DataBase Reference)

化学的性質

化学的特性White or almost white, crystalline powder.

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

GHS分類

GHS Classification · 4 件

Warning

H302 (99.1%): Harmful if swallowed [Warning Acute toxicity, oral]

P203, P264, P270, P273, P280, P301+P317, P318, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 116 reports by companies from 15 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

危険有害性情報

Regulatory Information(+)-Sertraline hydrochloride: Does not have an individual approval but may be used under an appropriate group standard
Hazard Classes and CategoriesAcute Tox. 4 (99.1%)

毒性情報

Treatment · 1 件

Treatment should consist of those general measures employed in the management of overdosage with any antidepressant. Ensure an adequate airway, oxygenation and ventilation. Monitor cardiac rhythm and vital signs. General supportive and symptomatic measures are also recommended. Induction of emesis is not recommended. Gastric lavage with a large-bore orogastric tube with appropriate airway protection, if needed, may be indicated if performed soon after ingestion, or in symptomatic patients. Activated charcoal should be administered. Due to large volume of distribution of this drug, forced diuresis, dialysis, hemoperfusion and exchange transfusion are unlikely to be of benefit. No specific antidotes for sertraline are known. (L1712)

Exposure Routes · 1 件

The effects of food on the bioavailability of the sertraline tablet and oral concentrate were studied in subjects administered a single dose with and without food. For the tablet, AUC was slightly increased when drug was administered with food but the Cmax was 25% greater, while the time to reach peak plasma concentration (Tmax) decreased from 8 hours post-dosing to 5.5 hours. For the oral concentrate, Tmax was slightly prolonged from 5.9 hours to 7.0 hours with food.

Toxicity Summary · 1 件

The exact mechanism of action sertraline is not fully known, but the drug appears to selectively inhibit the reuptake of serotonin at the presynaptic membrane. This results in an increased synaptic concentration of serotonin in the CNS, which leads to numerous functional changes associated with enhanced serotonergic neurotransmission. It is suggested that these modifications are responsible for the antidepressant action observed during long term administration of antidepressants. It has also been hypothesized that obsessive-compulsive disorder is caused by the dysregulation of serotonin, as it is treated by sertraline, and the drug corrects this imbalance.

Signs and SymptomsSymptoms of toxicity include alopecia, decreased libido, diarrhea, ejaculation disorder, fatigue, insomnia, somnolence and serotonin syndrome.
Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).
Drug Induced Liver Injury · 6 件

Drug Induced Liver Injury Rank (DILIrank 2.0)

Sertraline hydrochloride

vLess-DILI-concern

3

Adverse reactions

DOI:10.1016/j.drudis.2016.02.015

安全データ

wgk
3
rtecs
QJ0352070
ridadr
UN1230 - class 3 - PG 2 - Methanol, solution
hs_code
29214990
risk_code
36/37/38-39/23/24/25-23/24/25-11
hazard_code
Xi,T,F
safety_code
22-24/25-36-26-45-36/37-16-7
hazard_class
IRRITANT
Hazard Classifications
Acute Tox. 4 OralAquatic Acute 1Aquatic Chronic 1STOT RE 2
ストレージクラス
11 - Combustible Solids

化学と産業

薬理情報

Metabolism/Metabolites · 1 件

Extensively metabolized in the liver. Sertraline metabolism involves <i>N</i>-demethylation, <i>N</i>-hydroxylation, oxidative deamination, and glucuronidation of sertraline carbamic acid. Sertraline undergoes <i>N</i>-demethylation primarily catalyzed by cytochrome P450 (CYP) 2B6, with CYP2C19, CYP3A4 and CYP2D6 contributing to a lesser extent. Deamination occurs via CYP3A4 and CYP2C19. <i>In vitro</i> studies have shown that monoamine oxidase A and B may also catalyze sertraline deamination. Sertraline <i>N</i>-carbamoyl glucuronidation has also been observed in human liver microsomes. Route of Elimination: Sertraline is extensively metabolized and excretion of unchanged drug in urine is a minor route of elimination. Half Life: The elimination half-life of sertraline is approximately 25-26 hours. The elimination half-life of desmethylsertraline is approximately 62-104 hours.

FDA Pharmacological Classification · 4 件

SERTRALINE HYDROCHLORIDE

Cytochrome P450 2D6 Inhibitors [MoA]; Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

SERTRALINE HCL

Cytochrome P450 2D6 Inhibitors [MoA]; Serotonin Reuptake Inhibitor [EPC]; Serotonin Uptake Inhibitors [MoA]

MeSH Pharmacological Classification · 2 件

Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems.

Compounds that specifically inhibit the reuptake of serotonin in the brain.

用途と製造

Uses · 1 件

For the management of major depressive disorder, posttraumatic stress disorder, obsessive-compulsive disorder, panic disorder with or without agoraphobia, premenstrual dysphoric disorder, social phobia, premature ejaculation, and vascular headaches.

応用分野 · 7 件

用途選択的セロトニン取り込み阻 害剤(SSRI)です。

用途選択的セロトニン取り込み阻 害剤(SSRI)です。

用途強力で選択的セロトニン再取り込み阻害剤です(SSRI)。経口活性があります。

用途強力で選択的なセロトニン再取り込み阻害剤です(SSRI)。経口活性があります。

説明Sertraline hydrochloride is a selective serotonin reuptake inhibitor, similar mechanistically to fluoxetine, introduced initially for the maintenance and long-term treatment of depression. It is reportedly non-sedating and compared to fluoxetine has a shorter duration of action and lack of CNS activating effects such as nervousness and anxiety. Sertraline hydrochloride is currently undergoing investigation for the treatment of obesity and obsessive-compulsive disorders.

使用The effect of exposure of sertraline hydrochloride was studied in chronically prepared ovine fetus. It was used in glucocorticoid function assay to study the effect of antidepressants on glucocorticoid receptor function in humans.

一般的な説明Sertraline, marketed as the brand drug Zoloft, is an SSRI antidepressant used in the treatment of major depression as well as obsessive-compulsive, panic, and social anxiety disorders. This Certified Snap-N-Spike Solution is applicable for use in LC/MS or GC/MS applications for urine drug testing, clinical toxicology, and forensic analysis.

上流・下流製品情報

上流原料

カリウム tert-ブトキシドメチルアミン3,4-ジクロロベンゾフェノンセルトラリン塩化アルミニウム(III)塩化スルフィニル3,4-ジクロロベンゾイル クロリドこはく酸ジエチルD-(-)-マンデル酸塩化チタン( Ⅳ)水素臭化水素酸塩化ナトリウム
補足説明 · 1 件

定義ChEBI: A hydrochloride resulting from the reaction of equimolar amounts of sertraline and hydrogen chloride. A selective serotonin-reuptake inhibitor (SSRI), it is administered orally as an antidepressant for the treatment of depression, obsessive-compulsive diso der, panic disorder and post-traumatic stress disorder.

関連反応

106 件
反応記録を作成
HRID 6377 の反応式
HRID 6377生成物として
HRID 6378 の反応式
HRID 6378生成物として
HRID 25350 の反応式
HRID 25350生成物として
HRID 25351 の反応式
HRID 25351生成物として
HRID 347400 の反応式
HRID 347400生成物として
HRID 347401 の反応式
HRID 347401生成物として
HRID 347402 の反応式
HRID 347402生成物として
HRID 347403 の反応式
HRID 347403生成物として
前へ1 / 14 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート